Merck & Co., Inc. (LON:0QAH)
London · Delayed Price · Currency is GBP · Price in USD 101.80
+1.15 (1.15%)
At close: Dec 19, 2025
Merck & Co. Market Cap
Merck & Co. has a market cap or net worth of 187.61 billion as of December 19, 2025. Its market cap has decreased by -6.97% in one year.
Market Cap
187.61B
Enterprise Value
204.97B
Revenue
47.79B
Ranking
n/a
PE Ratio
13.25
Stock Price
101.80
Market Cap Chart
Since January 2, 1968, Merck & Co.'s market cap has increased from 3.01B to 187.61B, an increase of 6,141.58%. That is a compound annual growth rate of 7.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 187.61B | -6.67% |
| Dec 31, 2024 | 201.01B | -7.32% |
| Dec 29, 2023 | 216.89B | -7.10% |
| Dec 30, 2022 | 233.47B | 63.30% |
| Dec 31, 2021 | 142.97B | -5.68% |
| Dec 31, 2020 | 151.58B | -13.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.09B |
| GSK plc | 72.73B |
| Haleon | 32.99B |
| Smith & Nephew | 10.46B |
| Convatec Group | 4.73B |
| Hikma Pharmaceuticals | 3.34B |
| HUTCHMED (China) | 1.75B |
| Genus | 1.74B |